Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-05-30 Purchase | 2024-06-03 4:27 pm | AVITA Medical Inc. | RCEL | O'Toole David D CFO | 1,000 | $8.9 | $8,900 | 21,974 (Direct) | View |
| 2024-02-28 Purchase | 2024-02-28 4:04 pm | AVITA Medical Inc. | RCEL | O'Toole David D CFO | 1,250 | $17.39 | $21,738 | 18,734 (Direct) | View |
| 2023-12-12 Purchase | 2023-12-12 4:37 pm | AVITA Medical Inc. | RCEL | O'Toole David D CFO | 950 | $12.45 | $11,828 | 17,484 (Direct) | View |
| 2023-12-01 Purchase | 2023-12-04 7:06 pm | AVITA Medical Inc. | RCEL | O'Toole David D CFO | 500 | $10.68 | $5,340 | 16,534 (Direct) | View |
| 2023-11-21 Purchase | 2023-11-21 4:15 pm | AVITA Medical Inc. | RCEL | O'Toole David D CFO | 2,000 | $10.28 | $20,560 | 15,000 (Direct) | View |
| 2023-11-15 Purchase | 2023-11-16 2:38 pm | AVITA Medical Inc. | RCEL | O'Toole David D CFO | 2,000 | $12.3 | $24,600 | 13,000 (Direct) | View |
| 2023-11-14 Purchase | 2023-11-15 4:31 pm | AVITA Medical Inc. | RCEL | O'Toole David D CFO | 2,000 | $13.06 | $26,130 | 11,000 (Direct) | View |
| 2023-08-16 Purchase | 2023-08-16 5:57 pm | AVITA Medical Inc. | RCEL | O'Toole David D CFO | 2,000 | $17.05 | $34,110 | 9,000 (Direct) | View |
| 2023-08-15 Purchase | 2023-08-15 4:43 pm | AVITA Medical Inc. | RCEL | O'Toole David D CFO | 5,000 | $17.93 | $89,640 | 7,000 (Direct) | View |
| 2023-06-20 Purchase | 2023-06-21 6:50 pm | AVITA Medical Inc. | RCEL | O'Toole David D CFO | 1,000 | $16.15 | $16,150 | 2,000 (Direct) | View |
| 2023-01-27 Sale | 2023-01-31 4:17 pm | OPIANT PHARMACEUTICALS INC. | OPNT | O'Toole David D Chief Financial Officer | 541 | $20.26 | $10,961 | 34,248 (Direct) | View |
| 2023-01-09 Sale | 2023-01-09 5:16 pm | OPIANT PHARMACEUTICALS INC. | OPNT | O'Toole David D Chief Financial Officer | 415 | $20.2 | $8,383 | 34,789 (Direct) | View |
| 2023-01-05 Sale | 2023-01-05 5:03 pm | OPIANT PHARMACEUTICALS INC. | OPNT | O'Toole David D Chief Financial Officer | 1,600 | $20.2 | $32,320 | 35,204 (Direct) | View |
| 2022-07-14 Sale | 2022-07-15 4:06 pm | OPIANT PHARMACEUTICALS INC. | OPNT | O'Toole David D Chief Financial Officer | 779 | $11.1 | $8,647 | 36,804 (Direct) | View |
| 2022-01-10 Sale | 2022-01-12 4:39 pm | OPIANT PHARMACEUTICALS INC. | OPNT | O'Toole David D Chief Financial Officer | 432 | $30.6 | $13,219 | 35,583 (Direct) | View |
| 2021-09-14 Purchase | 2021-09-15 4:02 pm | OPIANT PHARMACEUTICALS INC. | OPNT | O'Toole David D Chief Financial Officer | 200 | $19.12 | $3,824 | 24,015 (Direct) | View |
| 2021-08-16 Purchase | 2021-08-16 4:47 pm | OPIANT PHARMACEUTICALS INC. | OPNT | O'Toole David D Chief Financial Officer | 600 | $15.38 | $9,228 | 23,815 (Direct) | View |
| 2020-06-11 Purchase | 2020-06-11 4:06 pm | OPIANT PHARMACEUTICALS INC. | OPNT | O'Toole David D Chief Financial Officer | 1,000 | $8.74 | $8,740 | 15,365 (Direct) | View |
| 2020-05-26 Purchase | 2020-05-26 4:25 pm | OPIANT PHARMACEUTICALS INC. | OPNT | O'Toole David D Chief Financial Officer | 1,000 | $11 | $11,000 | 14,365 (Direct) | View |
| 2019-11-26 Purchase | 2019-11-26 4:01 pm | OPIANT PHARMACEUTICALS INC. | OPNT | O'Toole David D Chief Financial Officer | 100 | $13.22 | $1,322 | 9,215 (Direct) | View |
| 2019-11-15 Purchase | 2019-11-15 4:02 pm | OPIANT PHARMACEUTICALS INC. | OPNT | O'Toole David D Chief Financial Officer | 1,100 | $14.92 | $16,410 | 9,115 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-05-31 Option Award | 2024-06-03 4:27 pm | N/A N/A | AVITA Medical Inc. | RCEL | O'Toole David D CFO | 2,240 | $8.1685 | 21,974 (Direct) | View |
| 2024-01-03 Option Award | 2024-01-05 5:49 pm | N/A 2033-01-03 | AVITA Medical Inc. | RCEL | O'Toole David D CFO | 125,000 | $0 | 125,000 (Direct) | View |
| 2023-11-30 Option Award | 2023-12-04 7:06 pm | N/A N/A | AVITA Medical Inc. | RCEL | O'Toole David D CFO | 1,034 | $9.061 | 16,534 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-16 4:25 pm | N/A 2033-06-15 | AVITA Medical Inc. | RCEL | O'Toole David D CFO | 150,000 | $0 | 150,000 (Direct) | View |
Ownership | 2023-06-16 4:20 pm | N/A N/A | AVITA Medical Inc. | RCEL | O'Toole David D CFO | 0 | $0 | 1,000 (Direct) | View |
| 2023-03-02 Option Award | 2023-03-03 08:57 am | N/A N/A | OPIANT PHARMACEUTICALS INC. | OPNT | O'Toole David D Chief Financial Officer | 2,000 | $0 | 0 (Direct) | View |
| 2023-03-02 Disposition | 2023-03-03 08:57 am | N/A N/A | OPIANT PHARMACEUTICALS INC. | OPNT | O'Toole David D Chief Financial Officer | 36,248 | $20 | 0 (Direct) | View |
| 2023-03-02 Disposition | 2023-03-03 08:57 am | N/A 2029-01-02 | OPIANT PHARMACEUTICALS INC. | OPNT | O'Toole David D Chief Financial Officer | 52,000 | $0 | 0 (Direct) | View |
| 2022-06-27 Option Award | 2022-06-29 4:04 pm | N/A N/A | OPIANT PHARMACEUTICALS INC. | OPNT | O'Toole David D Chief Financial Officer | 2,000 | $0 | 37,583 (Direct) | View |
| 2022-01-04 Option Award | 2022-01-05 4:21 pm | N/A N/A | OPIANT PHARMACEUTICALS INC. | OPNT | O'Toole David D Chief Financial Officer | 12,000 | $0 | 36,015 (Direct) | View |
| 2021-01-26 Option Award | 2021-01-27 4:20 pm | N/A 2031-01-26 | OPIANT PHARMACEUTICALS INC. | OPNT | O'Toole David D Chief Financial Officer | 18,600 | $0 | 33,965 (Direct) | View |
| 2020-01-07 Option Award | 2020-01-09 4:14 pm | 2020-02-07 2030-01-07 | OPIANT PHARMACEUTICALS INC. | OPNT | O'Toole David D Chief Financial Officer | 12,400 | $0 | 21,615 (Direct) | View |